Electrospider in the final at the National Innovation Award
The Electrospider bioprinter won a place in the final for the "National Award for Innovation" (PNI), after taking first place in the Start Cup Toscana 2022, the regional competition that rewarded innovative and technological ideas. The PNI is the most important business plan competition in Italy. The last act of the competition will be held in L'Aquila on 1 December.
Electrospider is an innovative 3D biofabrication technology patented by Bio3DPrinting, a company born from the collaboration between SolidWorld GROUP and the University of Pisa, capable of generating 3D cellular constructs having the complex topology of human tissues. The bioprinter represents an epochal evolution in the medical, pharmaceutical and cosmetic fields.
The goal of Electrospider is to use cells taken from the patient to bioprint perfectly functional organs. This allows to solve the problems related to the limited availability of organs for transplants.
Related posts
SolidWorld Group: spedita la biostampante Electrospider a un prestigioso ospedale svizzero
Prosegue la distribuzione su scala mondiale della prima piattaforma di medicina rigenerativa personalizzata tridimensionale per la ricerca oncologica e la creazione di tessuti umani impiantabili.
SolidWorld Group: la biostampante 3D Electrospider protagonista nel 3D Innovation Lab di Humanitas University
L’inclusione di Electrospider nel laboratorio consolida la collaborazione tra Humanitas University e SolidWorld Group, testimoniando l’impegno comune nel portare innovazione al servizio della medicina rigenerativa.
Bio3DPrinting su Impresa Sanità: la rivoluzione della stampa 3D nel campo medico
Leggi l’articolo completo pubblicato su Impresa Sanità, la rivista specializzata in notizie d’innovazione biomedicale